Research article
Trends towards an improved disease state in rheumatoid arthritis over time: influence of new therapies and changes in management approach: analysis of the EMECAR cohort
-
* Corresponding author: Isidoro González-Alvaro isidoro.ga@ser.es
1 Rheumatology Service, Hospital Universitario de la Princesa, c/Diego de León 62, Madrid 28006, Spain
2 Research Unit, Fundación Española de Reumatología, c/Marques del Duero 5, 1°, Madrid 28001, Spain
Arthritis Research & Therapy 2008, 10:R138 doi:10.1186/ar2561
Published: 26 November 2008Additional files
Additional file 1:
A Word file listing the collaborators in the EMECAR study.
Format: DOC Size: 24KB Download file
This file can be viewed with: Microsoft Word Viewer
Additional file 2:
An Adobe file containing a figure that shows the flowchart of the EMECAR study, providing relevant information about the dropouts along the follow-up.
Format: PDF Size: 78KB Download file
This file can be viewed with: Adobe Acrobat Reader
Additional file 3:
A Word file containing a table that presents the characteristics of the studied patients and the nonstudied patients in the multivariable analysis of each variable: disease activity, functional disability and radiological damage.
Format: RTF Size: 51KB Download file
Additional file 4:
An image file containing a graph of reasons for discontinuation during follow-up among therapies. The smaller the space between levels of different variables, the greater the association between them. AM, antimalarials; aTNF, TNF antagonists; GS, parenteral gold salts; LEF, leflunomide; MTX, methotrexate; SSZ, sulfasalazine.
Format: JPEG Size: 8KB Download file
